Short-term risk and long-term incidence rate of infection and malignancy with IL-23 inhibitors in adult patients with psoriasis and psoriatic arthritis: a systematic review and meta-analysis
Authors
Thanos Vassilopoulos
Infectious Diseases Division, Warren Alpert Medical School of Brown University & Rhode Island Hospital, Providence, RI, USA.
Keywords
psoriatic arthritis, opportunistic infection, JAK inhibitor, anti-IL-17, randomized controlled trials